Latest news
Loading news…
CoV Biotechnology is an early-stage biotechnology company focusing on the evolving and mutating nature of the coronavirus.
CoV Biotechnology was acquired by Leyden Labs in 2025.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Singapore, Central Region
1
professional contacts at CoV Biotechnology
Contact execs at CoV Biotechnology →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to CoV Biotechnology
Loading news…
FAQs about CoV Biotechnology
People who checked this page also checked these
Browse the full Acquirezy directory.